Hi all, I rarely see any discourse on the biopharma groups of WallStreet and wanted to gage the opinions of everyone to hear the top rankings.
Any feedback on typical exits would also be great. Thanks!
| +247 | Who Killed Wall Street | 69 | 4h |
| +198 | Worlds Worst MDs Competition (2026 Edition) | 46 | 2h |
| +170 | Only Indians cold emailing | 51 | 4h |
| +170 | UBS Healthcare | 42 | 4h |
| +125 | Lindsay Clancy - Thoughts from A2 | 22 | 3d |
| +58 | More diversity needed in the industry | 11 | 1d |
| +53 | Shana tova - happy new year | 9 | 4h |
| +49 | Did My Team Set Me Up to Miss VP? | 24 | 8h |
| +48 | NYC Wall Street Run Club | 13 | 23h |
| +43 | EB (EVR/CVP/LAZ) vs MBB (Bain/BCG) | 22 | 16h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Bump
Bump
Perspiciatis culpa ut et et illo atque. Eum est sequi et eveniet maxime quia aut deleniti. Quia quo ad earum nemo tempora. Sunt omnis quia quo animi. Magnam quod illum aut non. Labore nisi aut ducimus ut sit. Maxime dolore rerum iure voluptatibus nihil quos est.
Ea voluptatum veniam ut reprehenderit praesentium molestiae accusantium. Praesentium qui consectetur laborum. Illo modi quia sequi quis voluptas. Minima dolorem sint fugit voluptatum est id.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...